Results 51 to 60 of about 2,465 (209)

In vitro evaluation of doxorubicin-incorporated magnetic albumin nanospheres [PDF]

open access: yes, 2014
Magnetic albumin nanospheres that incorporate doxorubicin (M-DOX-BSA-NPs) were prepared previously by our research group to develop magnetically responsive drug carrier system.
Ak, Güliz   +4 more
core   +5 more sources

131 SPECT/CT of Abdominal False-Positive Uptake: Radioiodine Gallbladder Accumulation Mimics Hepatic Metastasis from Thyroid Carcinoma

open access: yesEndocrinology Research and Practice
The use of radioactive 131I (Iodine) to treat well-differentiated thyroid carcinomas is a well-established practice. However, in some cases, 131I may be retained in the gallbladder, leading to false-positive results in the detection of thyroid cancer ...
Mario Leporace   +2 more
doaj   +1 more source

Chitosan-based carbon quantum dots for biomedical applications: Synthesis and characterization [PDF]

open access: yes, 2019
Rapid development in medicine and pharmacy has created a need for novel biomaterials with advanced properties such as photoluminescence, biocompability and long-term stability.
Bogdał, Dariusz   +4 more
core   +1 more source

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

open access: yesAdvanced Materials, EarlyView.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa   +3 more
wiley   +1 more source

Long term biotransformation and toxicity of dimercaptosuccinic acid-coated magnetic nanoparticles support their use in biomedical applications [PDF]

open access: yes, 2014
Although iron oxide magnetic nanoparticles (MNP) have been proposed for numerous biomedical applications, little is known about their biotransformation and long-term toxicity in the body.
Barber, Domingo F.   +7 more
core   +1 more source

Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects

open access: yesAdvanced Materials, EarlyView.
Mesoporous silica nanoparticles offer unique properties like high surface area, tunable pores, and functionalization. They excel in drug delivery, tissue engineering, and stimuli‐responsive therapies, enabling targeted and controlled treatments. With roles in cancer therapy and diagnostics, their clinical translation requires addressing challenges in ...
Miguel Manzano, María Vallet‐Regí
wiley   +1 more source

Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis

open access: yesInternational Journal of Nanomedicine, 2022
Mesfin Dessale, Getachew Mengistu, Hylemariam Mihiretie Mengist Department of Medical Laboratory Sciences, Debre Markos University, Debre Markos, Amhara, EthiopiaCorrespondence: Hylemariam Mihiretie Mengist, Email hylemariam@gmail.comAbstract: Cancer ...
Dessale M, Mengistu G, Mengist HM
doaj  

Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress [PDF]

open access: yes, 2017
Cystic fibrosis (CF) infections are invariably biofilm-mediated and polymicrobial, being safe to assume that a myriad of factors affects the sociomicrobiology within the CF infection site and modulate the CF community dynamics, by shaping their social ...
Azevedo, Nuno Filipe   +2 more
core   +1 more source

Nanozymes at the Bio‐Nano Interface: From Synthesis, Defect Engineering, Catalytic Behavior in Biological Microenvironments, and Biosafety Implications

open access: yesAdvanced Materials Interfaces, EarlyView.
Nanozymes (NZs) have emerged as versatile artificial enzymes with tunable catalytic properties driven by atomic coordination, defect engineering, and surface chemistry. This review presents a bio–nano interface framework linking synthesis strategies, structural design, and catalytic behavior within complex biological microenvironments.
Karen Guadalupe Quintero‐Garrido   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy